REBECCA FOSTER: Open Payments
NPI 1063759744 · VIDALIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$146 in 7 payments from 4 companies in 2025. Trend: 2023 $590 · 2024 $312 · 2025 $146
Food & beverage: $146
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| Novo Nordisk Inc | 1 | $18 |
Products named: CAPLYTA, FARXIGA, LEQVIO, Rybelsus.
Industry payments across LA — which companies pay providers there.
